Literature DB >> 22595601

Single-balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography for treatment of cholangitis in a patient with a Kasai portoenterostomy.

Eric S Orman1, C Brock Miller, Ian S Grimm, A Sidney Barritt.   

Abstract

Primary therapy for biliary atresia is a surgical hepatoportoenterostomy (Kasai procedure), which has been shown to reduce mortality, but is frequently complicated by ascending cholangitis and the development of biliary cirrhosis. Previously reported therapy for recurrent cholangitis caused by biliary obstruction has included surgical revision and percutaneous biliary drainage, but endoscopic retrograde cholangiopancreatography has not been previously described. Here, we report a patient with recurrent cholangitis after a Kasai procedure and an anastomotic stricture successfully treated with single-balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography. This novel technique could be considered in patients with this common complication of the Kasai procedure and may impact long-term outcomes in this patient population.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22595601      PMCID: PMC3356930          DOI: 10.1016/j.jpedsurg.2011.12.017

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

1.  Safety of single-balloon enteroscopy: our experience of 72 procedures.

Authors:  M Manno; C Barbera; E Dabizzi; A Mussetto; R Conigliaro
Journal:  Endoscopy       Date:  2010-08-30       Impact factor: 10.093

2.  Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia.

Authors:  Mark Davenport; Mark D Stringer; Sarah A Tizzard; Patricia McClean; Giorgina Mieli-Vergani; Nedim Hadzic
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

3.  Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.

Authors:  Ling-Nan Bu; Huey-Ling Chen; Chee-Jen Chang; Yen-Hsuan Ni; Hong-Yuan Hsu; Hong-Shiee Lai; Wen-Ming Hsu; Mei-Hwei Chang
Journal:  J Pediatr Surg       Date:  2003-04       Impact factor: 2.545

4.  Acquired biliary atresia.

Authors:  M Davenport; R Saxena; E Howard
Journal:  J Pediatr Surg       Date:  1996-12       Impact factor: 2.545

5.  Long-term prognosis in biliary atresia after hepatic portoenterostomy: analysis of 35 patients who survived beyond 5 years of age.

Authors:  A Kobayashi; F Itabashi; Y Ohbe
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

6.  Surgical management of intractable cholangitis following successful Kasai procedure.

Authors:  R P Altman; K D Anderson
Journal:  J Pediatr Surg       Date:  1982-12       Impact factor: 2.545

7.  The Kasai portoenterostomy for biliary atresia: A review of a 27-year experience with 81 patients.

Authors:  Barbara E Wildhaber; Arnold G Coran; Robert A Drongowski; Ronald B Hirschl; James D Geiger; Joseph L Lelli; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2003-10       Impact factor: 2.545

Review 8.  Current concept about postoperative cholangitis in biliary atresia.

Authors:  Yi Luo; Shan Zheng
Journal:  World J Pediatr       Date:  2008-02       Impact factor: 2.764

9.  Biliary atresia: Swiss national study, 1994-2004.

Authors:  Barbara E Wildhaber; Pietro Majno; Johannes Mayr; Zacharias Zachariou; Judith Hohlfeld; Marcus Schwoebel; Walter Kistler; Martin Meuli; Claude Le Coultre; Gilles Mentha; Dominique Belli; Christophe Chardot
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-03       Impact factor: 2.839

10.  Late cholangitis after successful surgical repair of biliary atresia.

Authors:  F Gottrand; O Bernard; M Hadchouel; D Pariente; F Gauthier; D Alagille
Journal:  Am J Dis Child       Date:  1991-02
View more
  1 in total

Review 1.  Pediatric Biliary Interventions in the Native Liver.

Authors:  Lisa H Kang; Colin N Brown
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.